Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Anthony KC Chan, Chris Barnes, Mary Mathias, Silvia Linari, Francisco Jose Lopez Jaime, Lone Hvitfeldt Poulsen, Julien Bovet, Jan Odgaard-Jensen, Tadashi Matsushita

Blood (2023) 142 (Supplement 1): 30.

https://doi.org/10.1182/blood-2023-179739

Published: 2023

Journal Articles

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Amy D. Shapiro, Aby Abraham, Silvia Linari, Jesper Skov Neergaard, Jan Odgaard-Jensen, Jay Jay Thaung Zaw, Huyen Tran

Blood (2022) 140 (Supplement 1): 2732–2734.

https://doi.org/10.1182/blood-2022-166306

Published: 2022

Journal Articles

Clinical, Instrumental, Serological and Histological Findings Suggest That Hemophilia B May be Less Severe Than Hemophilia A

Giancarlo Castaman, MD, Daniela Melchiorre, MD, Silvia Linari, MD

Blood (2015) 126 (23): 4682.

https://doi.org/10.1182/blood.V126.23.4682.4682

Published: 2015

Journal Articles

Short and Long-Term Outcomes in Hemophilia Patients with Inhibitors Undergoing Orthopedic Prosthetic Surgery

Giancarlo Castaman, MD, Silvia Linari, MD, Christian Carulli, MD, Massimo Innocenti, MD

Blood (2015) 126 (23): 4704.

https://doi.org/10.1182/blood.V126.23.4704.4704

Published: 2015

Journal Articles

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

Maria E. Mancuso, MD, Elena Santagostino, MD, PhD, Maria G. Rumi, MD, Silvia Linari, MD, Antonio Coppola, MD, Angiola Rocino, MD, Alfonso Iorio, MD, Alfredo Dragani, MD, Giovanni Barillari, MD, Giuseppe Tagariello, MD, Roberto Nicolin, MD, Massimo Colombo, MD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 3219.

https://doi.org/10.1182/blood.V106.11.3219.3219

Published: 2005

Journal Articles

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus

Elena Santagostino, Massimo Colombo, Monica Rivi, Maria Grazia Rumi, Angiola Rocino, Silvia Linari, Pier Mannuccio Mannucci, for the the Study Group of the Association of Italian Hemophilia Centers

Blood (2003) 102 (1): 78–82.

https://doi.org/10.1182/blood-2002-10-3310

Published: 2003

Journal Articles

Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice

Alessandro Maria Vannucchi, Francesco Paoletti, Silvia Linari, Cristina Cellai, Roberto Caporale, Pierluigi Rossi Ferrini, Massimo Sanchez, Giovanni Migliaccio, Anna Rita Migliaccio

Blood (2000) 95 (8): 2559–2568.

https://doi.org/10.1182/blood.V95.8.2559

Published: 2000

NARROW

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Clinical, Instrumental, Serological and Histological Findings Suggest That Hemophilia B May be Less Severe Than Hemophilia A

Short and Long-Term Outcomes in Hemophilia Patients with Inhibitors Undergoing Orthopedic Prosthetic Surgery

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus

Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice

Email alerts

ASH Publications

American Society of Hematology

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Clinical, Instrumental, Serological and Histological Findings Suggest That Hemophilia B May be Less Severe Than Hemophilia A

Short and Long-Term Outcomes in Hemophilia Patients with Inhibitors Undergoing Orthopedic Prosthetic Surgery

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus

Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only